Hepatitis B virus functional cure in persons with HIV: what are the predictors and which novel markers are useful?
Low qHBsAg before or fast qHBsAg declines after initiating potent anti-HBV therapy has been identified as the most reliable predicting serum marker. Other markers might be useful in certain sub-populations and clinical situations.
Authors
- Andrew T. Boyd (ORCID: https://orcid.org/0000-0001-6354-6818)
- Fabien Zoulim (ORCID: https://orcid.org/0000-0002-2245-0083)
- Lorin Begré (ORCID: https://orcid.org/0000-0003-1015-8947)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- University of Bern (CH)
- Inserm (FR)
- Everest University (US)
- University Hospital of Bern (CH)
- University of Oxford (GB)
- Netherlands Center for Occupational Diseases (NL)
- Medawar Building for Pathogen Research (GB)
- Hospices Civils de Lyon (FR)
- Office of Infectious Diseases (US)
- Infectious Diseases Institute (UG)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Current Opinion in HIV and AIDS
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1097/coh.0000000000001002
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00